PNC Financial Services Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-242
| Closed | -$14.2K | – | 4867 |
|
2023
Q4 | $14.2K | Buy |
242
+3
| +1% | +$176 | ﹤0.01% | 3598 |
|
2023
Q3 | $10.4K | Buy |
239
+103
| +76% | +$4.49K | ﹤0.01% | 3746 |
|
2023
Q2 | $4.91K | Buy |
136
+18
| +15% | +$650 | ﹤0.01% | 4116 |
|
2023
Q1 | $4.39K | Sell |
118
-9
| -7% | -$335 | ﹤0.01% | 4081 |
|
2022
Q4 | $5.75K | Sell |
127
-240
| -65% | -$10.9K | ﹤0.01% | 3961 |
|
2022
Q3 | $25K | Buy |
367
+211
| +135% | +$14.4K | ﹤0.01% | 3358 |
|
2022
Q2 | $11K | Sell |
156
-89
| -36% | -$6.28K | ﹤0.01% | 3784 |
|
2022
Q1 | $20K | Buy |
245
+192
| +362% | +$15.7K | ﹤0.01% | 3588 |
|
2021
Q4 | $7K | Sell |
53
-25
| -32% | -$3.3K | ﹤0.01% | 3902 |
|
2021
Q3 | $15K | Buy |
78
+27
| +53% | +$5.19K | ﹤0.01% | 3631 |
|
2021
Q2 | $7K | Buy |
51
+21
| +70% | +$2.88K | ﹤0.01% | 3809 |
|
2021
Q1 | $4K | Buy |
30
+14
| +88% | +$1.87K | ﹤0.01% | 3880 |
|
2020
Q4 | $4K | Buy |
+16
| New | +$4K | ﹤0.01% | 3775 |
|
2020
Q3 | – | Sell |
-517
| Closed | -$59K | – | 4089 |
|
2020
Q2 | $59K | Sell |
517
-19,140
| -97% | -$2.18M | ﹤0.01% | 2674 |
|
2020
Q1 | $1.51M | Buy |
19,657
+4,694
| +31% | +$361K | ﹤0.01% | 813 |
|
2019
Q4 | $1.93M | Buy |
14,963
+3,713
| +33% | +$479K | ﹤0.01% | 823 |
|
2019
Q3 | $877K | Sell |
11,250
-85
| -0.7% | -$6.63K | ﹤0.01% | 1314 |
|
2019
Q2 | $1.17M | Buy |
+11,335
| New | +$1.17M | ﹤0.01% | 1219 |
|
2018
Q4 | – | Sell |
-7,820
| Closed | -$369K | – | 4212 |
|
2018
Q3 | $369K | Sell |
7,820
-5,290
| -40% | -$250K | ﹤0.01% | 1846 |
|
2018
Q2 | $647K | Buy |
13,110
+13,018
| +14,150% | +$642K | ﹤0.01% | 1504 |
|
2018
Q1 | $3K | Hold |
92
| – | – | ﹤0.01% | 4000 |
|
2017
Q4 | $2K | Hold |
92
| – | – | ﹤0.01% | 4031 |
|
2017
Q3 | $1K | Buy |
+92
| New | +$1K | ﹤0.01% | 4096 |
|